Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19.

MLA

Chew, Kara W., et al. “Antiviral and Clinical Activity of Bamlanivimab in a Randomized Trial of Non-Hospitalized Adults with COVID-19.” Nature Communications, 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1343801731&authtype=sso&custid=ns315887.

APA

Chew, K. W., Chew, K. W., Moser, C., Daar, E. S., Wohl, D. A., Li, J. Z., Coombs, R. W., Ritz, J., Giganti, M., Javan, A. C., Li, Y., Choudhary, M. C., Deo, R., Malvestutto, C., Klekotka, P., Price, K., Nirula, A., Fischer, W., Bala, V., … Smith, D. M. (2022). Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19. Nature Communications.

Chicago

Chew, Kara W, Kara W Chew, Carlee Moser, Eric S Daar, David A Wohl, Jonathan Z Li, Robert W Coombs, et al. 2022. “Antiviral and Clinical Activity of Bamlanivimab in a Randomized Trial of Non-Hospitalized Adults with COVID-19.” Nature Communications. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1343801731&authtype=sso&custid=ns315887.